Antimycotic rhamnolipid compositions and related methods of use
OwnerN.R. Gandhi, Victoria Skebba +2inventors
InventorsN.R. Gandhi, Victoria Skebba, Jon Takemoto, Mekki Bensaci
Life of this patent
Estimating the term…
Abstract
Antimycotic compositions comprising a rhamnolipid component and related methods of use.
Claims33
A composition comprising an antimycotic component selected from at least one syringomycin, at least one pseudomycin and combinations thereof;
- and a carrier component comprising a rhamnolipid.
A composition for inhibiting or preventing mycotic growth, said composition comprising an antimycotic component selected from a syringomycin, a pseudomycin and combinations thereof, said antimycotic component having an antimycotic activity;
- and a rhamnolipid surfactant component having another antimycotic activity, said composition providing an antimycotic activity greater than the sum of said component activities.
A method of using a rhamnolipid to improve antimycotic effect, said method comprising:
- providing an antimycotic component selected from a syringomycin, a pseudomycin and combinations thereof, said component having a first inhibitory concentration for mycotic growth inhibition;
- and
- contacting said antimycotic component and a rhamnolipid surfactant component, said rhamnolipid component in an amount at least partially sufficient to improve effect of said antimycotic component, said antimycotic component at a second inhibitory concentration less than said first inhibitory concentration.
A system comprising a substrate comprising at least one of a yeast membrane and a fungal membrane, and a composition thereon, said composition comprising an antimycotic component selected from a syringomycin, a pseudomycin and combinations thereof, and a carrier component comprising a rhamnolipid, said rhamnolipid in an amount at least partially sufficient to reduce the effective concentration of said antimycotic component on said mycotic membrane.
A method of inhibiting mycotic growth, said method comprising:
- providing a composition comprising an antimycotic component selected from a syringomycin, a pseudomycin and combinations thereof, and a rhamnolipid component;
- and
- contacting a substrate with said composition.
Dependencies are inferred from the claim text.